Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/39438660/?dopt=Abstract
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel...
Precision medicine in immune-mediated inflammatory diseases (IMIDs) requires a cellular understanding of treatment response. We describe a therapeutic atlas...
tumour necrosis factorsingle celllongitudinalatlasanti
https://www.cochrane.org/de/evidence/CD005112_tumour-necrosis-factor-alpha-blocking-agents-treatment-active-ulcerative-colitis
Tumour necrosis factor alpha blocking agents for treatment of active ulcerative colitis | Cochrane
tumour necrosis factoralphablockingagentstreatment
https://pubmed.ncbi.nlm.nih.gov/18625616/?dopt=Abstract
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months:...
There was suboptimal adherence to the Dutch guidelines for treatment with anti-TNF-alpha for rheumatoid arthritis patients. This seemed to be justified by the...
tumour necrosis factorguidelinescontinuationantitreatment
https://pubmed.ncbi.nlm.nih.gov/18725374/?ordinalpos=37&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor...
Cost-effectiveness ratios are within the commonly accepted willingness-to-pay threshold. These results need to be confirmed in larger samples of patients.
psoriatic arthritiscostevaluationstudyillness
https://www.wikidata.org/wiki/Q28593744
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but...
scientific journal article
tumour necrosis factormicereceptorresistant